Denavir (Prestium Pharma, Inc.)
Welcome to the PulseAid listing for the Denavir drug offered from Prestium Pharma, Inc.. This DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Prestium Pharma, Inc. |
NON-PROPRIETARY NAME: | penciclovir |
SUBSTANCE NAME: | PENCICLOVIR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-10-23 |
END MARKETING DATE: | 0000-00-00 |
Denavir HUMAN PRESCRIPTION DRUG Details:
Item Description | Denavir from Prestium Pharma, Inc. |
LABELER NAME: | Prestium Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/g) |
START MARKETING DATE: | 2012-10-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 40076-624_6b634e97-a6f8-4e46-9e73-88234d7fcc9f |
PRODUCT NDC: | 40076-624 |
APPLICATION NUMBER: | NDA020629 |
Other PENCICLOVIR Pharmaceutical Manufacturers / Labelers: